Figure 10 | Scientific Reports

Figure 10

From: Development of a disulfidptosis-related lncRNA prognostic signature for enhanced prognostic assessment and therapeutic strategies in lung squamous cell carcinoma

Figure 10

Immunotherapy and drug sensitivity differences between HRG and LRG. (A) Comparison of immunotherapy predictions between HRG and LRG according to the TIDE algorithm. (B-L) Differences in sensitivity to multiple drugs (Selumetinib, Paclitaxel, Trametinib, Afatinib, Erlotinib, Gefitinib, Osimertinib, Cisplatin, AZD4547, BI-2536, MK-2206) between the high and low-risk groups, respectively.

Back to article page